Elemental Impurities in Aspirin: USP <232>/<233> and ICH Q3D Methods Using ICP-OES

Application Note Pharma & Biopharma Analysis of Artificial Tear Eye Drops For Elemental Impurities Using an ICP-MS and USP <232>/<233> and ICH Q3D(R2)/Q2(R1) protocols. Authors Jennifer Sanderson and Lindsey Whitecotton Agilent Technologies, Inc. Introduction As pharmaceutical products are released to…

White Paper USP <232>/<233> and ICH Q3D Elemental Impurities Analysis: The Agilent ICP-OES Solution Elemental Impurity Analysis Requirements Worldwide, regulatory authorities are responsible for ensuring that pharmaceutical products are both effective and safe. To achieve this, potentially harmful contaminants—including elemental…

Application Note Biopharma Analysis of Elemental Impurities in Synthetic Oligonucleotides by ICP-MS Development and testing of an efficient Agilent 7850 ICP-MS method in compliance with USP <232>/<233> and ICH Q3D(R2)/Q2(R1) Authors Introduction Bian Yulan and Li Shuping Synthetic oligonucleotides are…

Application Note Pharmaceuticals Accurate and Robust Measurement of Elemental Impurities in Pharmaceuticals by ICP-MS Implementation of Indian Pharmacopeia General Chapter 5.10 compliant workflow using the Agilent 7850 ICP-MS Authors Vinay Jain and Prashnat Dour, Agilent Technologies, Inc. Introduction Elemental impurity…